Objectives: The ideal result of infrainguinal bypass (IBP) with in-line flow to the foot should be a normal hemodynamic result indicated by a palpable pulse/normal ankle-brachial index (ABI). The results of intervention can vary depending on inflow and outflow of the bypass and the quality and type of conduit chosen. The object of this study is to identify outcome depending on the hemodynamic result after IBP.
Objectives: The ideal result of infrainguinal bypass (IBP) with in-line flow to the foot should be a normal hemodynamic result indicated by a palpable pulse/normal ankle-brachial index (ABI). The results of intervention can vary depending on inflow and outflow of the bypass and the quality and type of conduit chosen. The object of this study is to identify outcome depending on the hemodynamic result after IBP.
Methods: National Vascular Quality Initiative (VQI) data from 2003 to 2017 were queried to identify patients with CLI and claudication treated with IBP with primary patency at 1 year. The outcome of interest was maintenance of ABI between 0.9 and 1.3 (normal ABI) at 1 year. Exclusions included patients with noncompressible tibial vessels, those without postoperative ABI and 1 year follow-up, and those with prior ipsilateral infrainguinal endovascular intervention or IBP. Of a total of 37,970 patients, 1519 met our selection criteria. Cohorts perfusion grade were: ABIs 0 to 0.5, (n ¼ 206), ABIs 0.5 to 0.9 (n ¼ 665), and ABIs 0.9 to 1.3 (n ¼ 648; Table I ). Demographics and procedural factors were evaluated for predictors of failure to maintain unassisted normal ABI at 1 year using multivariable logistic regression. Stepwise regression was used for variables with P < .2 from c 2 or t test analysis.
Results:
Of the 648 patients with a normal ABI at discharge, 79.6% maintained a normal ABI at one year follow-up, and 2 patients underwent major amputation. When discharged with an ABI of <0.9, 54.7% had a subsequent ABI measured at >0.9 at the 1-year follow-up and a total of six major amputations occurred. In patients with a normal ABI at discharge, multivariable analysis demonstrated that any history of nonindex limb peripheral vascular intervention, coronary artery disease, concomitant endarterectomy, diabetes, pedal bypass target, postoperative congestive heart failure, or sequential graft were predictive of a drop in ABI at 1 year to <0.9. (Table II) . The discharge ABI 0.5 to 0.9 cohort multivariable analysis showed that hypertension, female gender, postoperative myocardial infarction, and nonwhite race were predictive of poor hemodynamic result; use of vein conduit and preop ABI grade were protective of a maintained ABI at the 1-year follow-up (Table II) .
Conclusions: These results suggest that patients with a normal ABI immediately after bypass have a high likelihood of maintaining a normal hemodynamic response at one year, irrespective of conduit choice. However, conduit type, among other factors, becomes important when postoperative perfusion results are not optimal. Objectives: Patients undergoing bypass for lower extremity ischemia (LEI) require intensive health care resource use. Prior study has demonstrated that these patients frequently require rehab or skilled nursing homes following surgical intervention, yet little study has evaluated whether it is possible to predict non-home discharge (NHD) in this patient population. Early preoperative identification of those at high risk for NHD may help improve preoperative counselling and hospital efficiency in providing appropriate resources to those who need it. This study sought to predict NHD using preoperative risk-factors in patients undergoing bypass for LEI using a novel risk score.
Methods: The Vascular Study Group of New England (VSGNE) was queried for patients undergoing suprainguinal or infrainguinal bypass for LEI from years 2003 to 2017. Cases were excluded if they were not admitted from home, if they were bedridden, or died during the index admission. The primary end point was NHD. The data was split twothirds for model derivation and one-third for validation. Factors were evaluated for model inclusion by virtue of meeting P < .1 on bivariate analysis. A parsimonious manual stepwise binary logistic regression for NHD was performed maximizing the C-statistic while maintaining model simplicity for clinical use. A risk score was then developed using beta coefficients and applied to the dataset. The risk score performance was assessed in both the developmental and validation datasets.
Results: Overall 10,145 cases were included with an NHD rate of 26.4% (n ¼ 2,676). Mean age was 66 years (range, 41-90years). NHD patients were older (72 years vs 64 years; P < .01) more frequently male (57.2% vs 42.8%, P < .01), non-white (16.1% vs 9.9%, P < .01), and had tissue loss (54.2% vs 23.0%, P < .01), anemia (16.0% vs 5.3%, P < .01), severe cardiac comorbidity (21.8% vs 10.5%, P < .01), and insulin dependent diabetes (IDDM; 33.3% vs 18.2%, P < .01). On multivariable analysis factors associated with NHD included age, non-white, tissue-loss, cardiac comorbidity partial ambulatory deficit and IDDM (Table) . The C-statistic was 0.78 in the derivation group and 0.79 in the validation group with Hosmer-Lemeshow P > .999. The risk score ranged from 0 to 18 with a mean score of 4 Objectives: Below-knee amputation (BKA) for lower extremity infection may be performed as a single operation, or as a two-stage procedure with guillotine amputation and subsequent formalization. BKA failure owing to recurrent infection or necrosis is associated with significant morbidity; however, it is unclear whether the potential benefits of staging outweigh the risk of an additional operation. Here, we compare the effectiveness of two-stage BKA to single-stage BKA for lower extremity infection.
Methods: A retrospective review was performed of all patients who underwent BKA for lower extremity infection at our urban limb salvage center from 2011 to 2016. The study population was divided into those who underwent two-stage BKA versus those who underwent single-stage BKA. The primary end point was failure of the BKA surgery, defined as need for surgical revision, unplanned conversion to above-knee amputation (AKA), or mortality within six weeks. Secondary end points included postoperative complications and time to discharge.
Results: Of 205 limbs among 198 patients in the study, 100 (48.8%) underwent single-stage BKA and 105 (51.2%) underwent two-stage BKA. There was no significant difference in age, Charleston Comorbidity Index, or American Society of Anesthesiologists score between groups. Two-stage operations had higher rates of leukocytosis (P < .001), and diabetes (P < .001) with perioperative hyperglycemia (P < .001). Of the 19 BKAs that failed (9.3%), 12 occurred after single-stage amputation (16.6%) versus 7 after two-stage amputation (8.4%); this was not significant (P ¼ .18). There was no difference in the incidence of perioperative mortality or major complications (7.6% two-stage vs 7.0% one-stage; P ¼ .86). In the subset of patients with systemic infection as evidenced by perioperative leukocytosis (155 limbs, 75.6%), a significant reduction in failure was associated with two-stage amputation (4.8% two-stage vs 13.8% one-stage; P ¼ .048), but this was not preserved in the absence of leukocytosis (7% one-stage vs 13.6% two-stage; P ¼ .69). Two-stage BKA was associated with longer hospital stays (17.5 vs 13.7 days; P ¼ .006), greater transfusion need (P ¼ .045) and higher rates of acute kidney injury (P ¼ .045).
Conclusions: In this retrospective study, two-stage below-knee amputation was not associated with lower rates of BKA failure compared with single-stage operation, and was associated with higher rates of certain complications and a longer hospital stay. Although two-stage BKA seems to be the operation of choice in the setting of systemic infection, this benefit was not seen for only local infection.
Further prospective research will help to more clearly identify the subset of patients with foot infections that may safely undergo a singlestage BKA.
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Evaluation of Incomplete Lower Extremity Duplex Venous Ultrasound Examinations
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Objectives: Deep venous thrombosis (DVT) positive lower extremity venous duplex ultrasound (LEVDUS) examination is an indication for anticoagulation. Incomplete examinations that fail to examine all LE veins in patients not otherwise indicated for anticoagulation may be followed by a repeat examination to exclude missed/progressing DVT. This study examined the frequency of follow-up LEVDUS following incomplete LEV-DUS and compared the incidence of positive DVT between initial complete LEVDUS and follow-up LEVDUS after an initial incomplete examination to determine if improving rates of follow-up LEVDUS following an incomplete examination is a reasonable target for quality improvement.
Methods: From December 2016 to December 2017, incomplete LEVDUS were prospectively identified in patients who did not have an identified indication for anticoagulation. We determined the frequency/ demographics of repeat studies performed within 2 weeks after incomplete LEVDUS and DVT rates of initial and repeat LEVDUS.
Results: There were 4,828 LEVDUS studies (ankle to groin) performed; 223 (4.8%) were incomplete and did not otherwise identify DVT in the ipsilateral or contralateral leg. Of incomplete studies, 80.3% were ordered in-hospital, 12.1% from outpatient clinics, 7.6% from the ED, with 9.9% ordered by primary care providers, 33.6% by specialists, 29.1% by trauma surgeons and 27.4% by emergency department providers. Initial indications for incomplete studies were high-risk screening in 52.5%, and LE signs/symptoms in 47.5%. In addition, 63.2% of incomplete studies resulted from bandages, wounds, braces, casts or fixation devices, 13.5% from edema, 5.8 % from body habitus and 12.1% from patient study intolerance. Deep veins inadequately evaluated on initial LEVDUS included femoral (36.8%), popliteal (40%) and axial calf veins (85.7%). Sixty-one patients (27.3%) with incomplete LEVDUS had repeat examinations. 11.5% had thrombi detected with six in deep and two in superficial veins. Only 18 of 105 symptomatic patients with an incomplete study had a repeat study with 71% of follow-up studies for screening patients (P < .001). DVT diagnosis rates were similar between initial complete LEVDUSs (8.7%) and repeat LEVDUSs performed after an initial incomplete examination (8.2%; P ¼ .65).
Conclusions: Almost one-half of incomplete LEVDUSs are ordered in symptomatic patients. However, the large majority of patients with incomplete LEVDUS, even those with symptoms, do not have a followup examination but patients with repeat studies have a DVT diagnosis rate equivalent to patients with an initial complete examination, suggesting the need for quality assurance programs to ensure repeat studies are performed after incomplete LEVDUS, particularly in symptomatic patients.
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